Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
CHA University
CHA University
The Institute of Molecular and Translational Medicine, Czech Republic
Boston Children's Hospital
University Health Network, Toronto
Jewish General Hospital
Rigshospitalet, Denmark
M.D. Anderson Cancer Center
University of Southern California
CHA University
SOLTI Breast Cancer Research Group
University Hospital, Montpellier
Huashan Hospital
SOLTI Breast Cancer Research Group
Helse Nord-Trøndelag HF